Back
Enanta Pharmaceuticals Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
11
ENTA
Enanta Pharmaceuticals
Last Price:
$5.99
Seasonality Move:
7.84%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Enanta Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.12 | Sell |
| 20-day SMA: | 7.38 | Sell |
| 50-day SMA: | 9.56 | Sell |
| 200-day SMA: | 12.36 | Sell |
| 8-day EMA: | 6.37 | Sell |
| 20-day EMA: | 7.28 | Sell |
| 50-day EMA: | 8.89 | Sell |
| 200-day EMA: | 12.02 | Sell |
Enanta Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.02 | Sell |
| Relative Strength Index (14 RSI): | 30.47 | Sell |
| Chaikin Money Flow: | 138926 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.45 - 9.05) | Sell |
| Bollinger Bands (100): | (8.73 - 12.77) | Sell |
Enanta Pharmaceuticals Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enanta Pharmaceuticals Stock
Is Enanta Pharmaceuticals Stock a Buy?
-
Enanta Pharmaceuticals share price is 6.10 while ENTA 8-day simple moving average is 6.12, which is a Sell signal.
-
The stock price of ENTA is 6.10 while Enanta Pharmaceuticals 20-day SMA is 7.38, which makes it a Sell.
-
Enanta Pharmaceuticals 50-day simple moving average is 9.56 while ENTA share price is 6.10, making it a Sell technically.
-
ENTA stock price is 6.10 and Enanta Pharmaceuticals 200-day simple moving average is 12.36, creating a Sell signal.
ENTA Technical Analysis vs Fundamental Analysis
Sell
11
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy or a Sell?
-
Enanta Pharmaceuticals stock is rated a SellThe current Enanta Pharmaceuticals [ENTA] share price is $6.10. The Score for ENTA is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
Enanta Pharmaceuticals Stock Info
Market Cap:
129.3M
Price in USD:
6.10
Share Volume:
241.8K
Enanta Pharmaceuticals 52-Week Range
52-Week High:
17.80
52-Week Low:
5.70
Sell
11
Enanta Pharmaceuticals (ENTA)
is a Sell
Enanta Pharmaceuticals Share Price Forecast
-
What is the Enanta Pharmaceuticals stock price today?The Enanta Pharmaceuticals stock price is 6.10 USD today.
-
Will ENTA stock go up or go down?Enanta Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Enanta Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enanta Pharmaceuticals is overvalued.
Is Enanta Pharmaceuticals Stock a Buy?
-
Enanta Pharmaceuticals share price is 6.10 while ENTA 8-day exponential moving average is 6.37, which is a Sell signal.
-
The stock price of ENTA is 6.10 while Enanta Pharmaceuticals 20-day EMA is 7.28, which makes it a Sell.
-
Enanta Pharmaceuticals 50-day exponential moving average is 8.89 while ENTA share price is 6.10, making it a Sell technically.
-
ENTA stock price is 6.10 and Enanta Pharmaceuticals 200-day simple moving average is 12.02, creating a Sell signal.
Fundamental Analysis of Enanta Pharmaceuticals
Is Enanta Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.01 per share, and a decrease next year of $0.32 per share.
Technical Analysis of Enanta Pharmaceuticals
Should I short Enanta Pharmaceuticals stock?
-
ENTA Moving Average Covergence Divergence (MACD) indicator is -1.02, suggesting Enanta Pharmaceuticals is a Sell
-
Enanta Pharmaceuticals Relative Strength Index (RSI) is 30.47, which suggest Enanta Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Enanta Pharmaceuticals is (6.45 - 9.05), which suggest Enanta Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Enanta Pharmaceuticals is (8.73 - 12.77), which suggest Enanta Pharmaceuticals is a Sell
* Enanta Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.